Abstract: According to at least one example embodiment, a substrate treating apparatus includes a substrate support structure including a spin head, the substrate support structure configured to support a substrate, and rotate the substrate, at least one treating liquid recovery container configured to recover at least one substrate treating liquid, and a discharging device including a first nozzle and a second nozzle, the first nozzle configured to discharge a chemical onto the substrate, and the second nozzle configured to discharge deionized water onto the substrate, wherein the first nozzle includes a surface pattern configured to provide roughness on an inner surface of the first nozzle.

Abstract: A cylindrical secondary battery module includes: a plurality of cylindrical secondary battery cells respectively having a battery case in which an electrode assembly and an electrolyte are accommodated; a cell frame at which the plurality of cylindrical secondary battery cells are disposed; and a lid coupled to the cell frame and having a flame outlet. The cell frame includes: a plurality of plate members bent and coupled to intersect each other; and a space formed between the plurality of plate members so that the cylindrical secondary battery cells are disposed therein.

Abstract: Disclosed herein are a decoding method and apparatus and an encoding method and apparatus for deriving an intra-prediction mode. An intra-prediction mode may be derived using a method for deriving an intra-prediction mode based on a neighbor block of the target block, a method for deriving an intra-prediction mode using signaling of the intra-prediction mode of the target block, or a method for deriving an adaptive intra-prediction mode based on the type of a target slice. An MPM list may be used to derive the intra-prediction mode, and a temporal neighbor block or the like may be used to configure the MPM list.

Abstract: There is provided an additive, containing magnesium silicate, for a secondary battery electrolyte and a preparation method therefor. The magnesium silicate has a mass ratio of 50 to 70 wt % of oxygen (O), 5 to 20 wt % of magnesium (Al), and 15 to 35 wt % of silicon (Si). The magnesium silicate has a surface area of 50 to 500 m2/g. The magnesium silicate has a pore size of 0.1 to 20 nm.

Abstract: There is provided an additive for secondary battery electrolyte, containing aluminum silicate. The aluminum silicate has a particle size of 200 nm to 20 ?m. The aluminum silicate has a mass ratio of 60 to 70 wt % of oxygen (O), 0.1 to 2.0 wt % of aluminum (Al), and 25 to 35 wt % of silicon (Si). The aluminum silicate has a surface area of 50 to 1,000 m2/g. The aluminum silicate has a pore size of 0.1 to 20 nm.

Abstract: Disclosed herein are a decoding method and apparatus and an encoding method and apparatus that perform inter-prediction using a motion vector predictor. For a candidate block in a col picture, a scaled motion vector is generated based on a motion vector of the candidate block. When the scaled motion vector indicates a target block, a motion vector predictor of the target block is generated based on the motion vector of the candidate block. The motion vector predictor is used to derive the motion vector of the target block in a specific inter-prediction mode such as a merge mode and an AMVP mode.

Abstract: Provided is a method of manufacturing a light-emitting element, the method including positioning a substrate, forming a first separation layer, which includes a first sacrificial layer, an etching control layer on the first sacrificial layer, and a second sacrificial layer on the etching control layer, on the substrate, forming at least one first light-emitting element on the first separation layer, and separating the first light-emitting element from the substrate.

Abstract: An image encoding/decoding method is provided. An image decoding method of the present invention may comprise deriving an intra-prediction mode of a current luma block, deriving an intra-prediction mode of a current chroma block based on the intra-prediction mode of the current luma block, generating a prediction block of the current chroma block based on the intra-prediction mode of the current chroma block, and the deriving of an intra-prediction mode of a current chroma block may comprise determining whether or not CCLM (Cross-Component Linear Mode) can be performed for the current chroma block.

Abstract: An apparatus for providing brain lesion information based on an image includes a magnetic resonance angiography (MRA) provider configured to provide an environment capable of displaying 3D time-of-flight magnetic resonance angiography (3D TOF MRA) using user input, a brain lesion input unit configured to generate and manage a brain lesion image, a maximum intensity projection (MIP) converter configured to configure MIP image data including at least one image frame corresponding to a projection position of the brain lesion image, a noise remover configured to remove noise of brain lesion information and to configure corrected MIP image data, from which the noise is removed, and an MRA reconfiguration unit configured to reconfigure a corrected brain lesion image by back-projecting the corrected MIP image data.

Abstract: An apparatus for evaluating validity of detection of a cancer region may be provided.

Abstract: A deep learning model learning device is proposed, including: a parametric MRI image input part inputting an image corresponding to a diagnosis region, inputting at least one parametric MRI image constructed on the basis of parameters different from each other, and constructing and providing an MRI moving image by using the at least one parametric MRI image; a cancer detection model learning part receiving an input of the at least one parametric MRI image and the MRI moving image corresponding to the diagnosis region, and learning a deep learning model on the basis of information labeling the cancer region; a labeling reference information providing part providing at least one reference information contributing to the labeling of the cancer region; and a labeling processing part checking the cancer region input on the basis of the at least one reference information and processing the labeling of the checked cancer region.

Abstract: Provided herein are water soluble salts of Formula I, wherein R1, A, and M are defined herein. Also provided herein are methods of preparing the salts of Formula I and methods of using the same.

Abstract: A storage controller for writing first data to a first memory cell by performing programming of the first memory cell N-times, where N is a positive integer greater than 1, includes a write amplification manager and a central processing unit. The write amplification manager checks whether the first data is invalid data before an Nth programming of the first memory cell is performed, and the central processing unit does not perform the N-th programming of the first memory cell when the first data is the invalid data.

Abstract: A lower cross member for a vehicle is disposed on a floor of a vehicle. The lower cross member includes a core member and a reinforcing layer. The core member is made of a composite material containing 70 wt. % or more of unidirectional carbon fibers, and the reinforcing layer is made of a composite material containing 70 wt. % or more of fiberglass.

Abstract: Provided are a resin composition for a tackifier or an adhesive and a preparation method thereof. Provided is a resin composition for a tackifier or an adhesive, which includes a hydrogenated petroleum resin with a controlled hydrogenation rate to have excellent compatibility with polyolefin and to exhibit high transparency while having improved quality including adhesive property.

Abstract: Novel N2-phenylpyrimidine-2,4-diamine compounds, method for preparing the same, and pharmaceutical composition or health functional food are disclosed. The novel N2-phenylpyrimidine-2,4-diamine compounds show potent inhibitory efficacies on EGFR mutations and thus, can be effectively used for the treatment of cancer with EGFR mutations.

Abstract: The present invention relates to a pharmaceutical formulation having excellent bioavailability and stability, comprising sodium palmitoyl-L-prolyl-L-prolyl-glycyl-L-tyrosinate (Compound I) as an active ingredient. The pharmaceutical formulation according to the present invention can be usefully used as a dosage form for treating inflammatory bowel disease and the like since Compound I, an active ingredient, is not decomposed in the stomach and released in the intestine.

Abstract: Proposed is a system for executing a task of an operating system for a vehicle, the system including: a task information extracting unit which, when an event signal is received from an application, extracts task information related to the event signal from a pre-prepared event chain table; an execution cycle setting unit which sets a task execution cycle by using the extracted task information; a task executing unit which executes any one task among a plurality of tasks according to the task execution cycle; and a waiting time providing unit which provides a task waiting time to the task executing unit so as to wait for execution of a next task when the execution of the one task is completed.